{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:36:02Z","timestamp":1794411362564,"version":"4.9.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chinese Society of Cardiology\u2019s Foundation","award":["CSCF2021A02"],"award-info":[{"award-number":["CSCF2021A02"]}]},{"name":"Chinese Society of Cardiology\u2019s Foundation","award":["CSCF2021A02"],"award-info":[{"award-number":["CSCF2021A02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-93379-6","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T09:19:07Z","timestamp":1743499147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association between mild renal insufficiency, inflammatory status on initial admission, and 1-year mortality following ST-segment elevation myocardial infarction"],"prefix":"10.1038","volume":"15","author":[{"given":"Da","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bofang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changwu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"93379_CR1","unstructured":"US Renal Data System. Annual Data Report. Accessed March 19, 2024. https:\/\/usrds-adr.niddk.nih.gov\/2023\/chronic-kidney-disease (2023)."},{"issue":"9887","key":"93379_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0140-6736(13)60439-0","volume":"382","author":"KU Eckardt","year":"2013","unstructured":"Eckardt, K. U. et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet 382 (9887), 158\u2013169. https:\/\/doi.org\/10.1016\/S0140-6736(13)60439-0 (2013).","journal-title":"Lancet"},{"issue":"11","key":"93379_CR3","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","volume":"143","author":"J Jankowski","year":"2021","unstructured":"Jankowski, J., Floege, J., Fliser, D., B\u00f6hm, M. & Marx, N. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation 143 (11), 1157\u20131172. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.050686 (2021).","journal-title":"Circulation"},{"issue":"11","key":"93379_CR4","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41581-022-00616-6","volume":"18","author":"K Matsushita","year":"2022","unstructured":"Matsushita, K. et al. Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat. Rev. Nephrol. 18 (11), 696\u2013707. https:\/\/doi.org\/10.1038\/s41581-022-00616-6 (2022).","journal-title":"Nat. Rev. Nephrol."},{"issue":"11","key":"93379_CR5","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.jacc.2021.01.028","volume":"77","author":"AC Lai","year":"2021","unstructured":"Lai, A. C. et al. A personalized approach to chronic kidney disease and cardiovascular disease: JACC review topic of the week. J. Am. Coll. Cardiol. 77 (11), 1470\u20131479. https:\/\/doi.org\/10.1016\/j.jacc.2021.01.028 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9731","key":"93379_CR6","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","volume":"375","author":"Association of estimated glomerular filtration rate","year":"2010","unstructured":"Association of estimated glomerular filtration rate. And albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375 (9731), 2073\u20132081. https:\/\/doi.org\/10.1016\/S0140-6736(10)60674-5 (2010).","journal-title":"Lancet"},{"issue":"9889","key":"93379_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","volume":"382","author":"RT Gansevoort","year":"2013","unstructured":"Gansevoort, R. T. et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 382 (9889), 339\u2013352. https:\/\/doi.org\/10.1016\/S0140-6736(13)60595-4 (2013).","journal-title":"Lancet"},{"key":"93379_CR8","doi-asserted-by":"publisher","unstructured":"K L, W. D Immunity and inflammation in atherosclerosis. Circ. Res. 124 (2). https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313591 (2019).","DOI":"10.1161\/CIRCRESAHA.118.313591"},{"issue":"10","key":"93379_CR9","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1161\/CIRCRESAHA.118.313816","volume":"123","author":"K Kobiyama","year":"2018","unstructured":"Kobiyama, K., Ley, K. & Atherosclerosis Circ. Res. ;123(10):1118\u20131120. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313816 (2018).","journal-title":"Circ. Res."},{"issue":"11","key":"93379_CR10","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/nm.2538","volume":"17","author":"C Weber","year":"2011","unstructured":"Weber, C. & Noels, H. Atherosclerosis: current pathogenesis and therapeutic options. Nat. Med. 17 (11), 1410\u20131422. https:\/\/doi.org\/10.1038\/nm.2538 (2011).","journal-title":"Nat. Med."},{"issue":"17","key":"93379_CR11","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.jacc.2016.01.073","volume":"67","author":"PC Westman","year":"2016","unstructured":"Westman, P. C. et al. Inflammation as a driver of adverse left ventricular remodeling after acute myocardial infarction. J. Am. Coll. Cardiol. 67 (17), 2050\u20132060. https:\/\/doi.org\/10.1016\/j.jacc.2016.01.073 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"93379_CR12","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1177\/2048872615568965","volume":"5","author":"IM Seropian","year":"2016","unstructured":"Seropian, I. M., Sonnino, C., Van Tassell, B. W., Biasucci, L. M. & Abbate, A. Inflammatory markers in ST-elevation acute myocardial infarction. Eur. Heart J. Acute Cardiovasc. Care. 5 (4), 382\u2013395. https:\/\/doi.org\/10.1177\/2048872615568965 (2016).","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"issue":"16","key":"93379_CR13","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/j.jacc.2014.01.014","volume":"63","author":"IM Seropian","year":"2014","unstructured":"Seropian, I. M., Toldo, S., Van Tassell, B. W. & Abbate, A. Anti-inflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarction. J. Am. Coll. Cardiol. 63 (16), 1593\u20131603. https:\/\/doi.org\/10.1016\/j.jacc.2014.01.014 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"93379_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12933-021-01222-9","volume":"20","author":"P Paolisso","year":"2021","unstructured":"Paolisso, P. et al. Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA. Cardiovasc. Diabetol. 20 (1), 33. https:\/\/doi.org\/10.1186\/s12933-021-01222-9 (2021).","journal-title":"Cardiovasc. Diabetol."},{"issue":"9731","key":"93379_CR15","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","volume":"375","author":"Chronic Kidney Disease Prognosis Consortium","year":"2010","unstructured":"Chronic Kidney Disease Prognosis Consortium et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet Lond. Engl. 375 (9731), 2073\u20132081. https:\/\/doi.org\/10.1016\/S0140-6736(10)60674-5 (2010).","journal-title":"Lancet Lond. Engl."},{"issue":"11","key":"93379_CR16","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1093\/cvr\/cvad083","volume":"119","author":"C Zoccali","year":"2023","unstructured":"Zoccali, C. et al. Cardiovascular complications in chronic kidney disease: a review from the European renal and cardiovascular medicine working group of the European renal association. Cardiovasc. Res. 119 (11), 2017\u20132032. https:\/\/doi.org\/10.1093\/cvr\/cvad083 (2023).","journal-title":"Cardiovasc. Res."},{"issue":"11","key":"93379_CR17","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/CIRCULATIONAHA.121.053547","volume":"144","author":"SJ Schunk","year":"2021","unstructured":"Schunk, S. J. et al. Interleukin-1\u03b1 is a central regulator of Leukocyte-Endothelial adhesion in myocardial infarction and in chronic kidney disease. Circulation 144 (11), 893\u2013908. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.053547 (2021).","journal-title":"Circulation"},{"issue":"12","key":"93379_CR18","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1001\/jamacardio.2021.3079","volume":"6","author":"G Batra","year":"2021","unstructured":"Batra, G. et al. Interleukin 6 and cardiovascular outcomes in patients with chronic kidney disease and chronic coronary syndrome. JAMA Cardiol. 6 (12), 1440\u20131445. https:\/\/doi.org\/10.1001\/jamacardio.2021.3079 (2021).","journal-title":"JAMA Cardiol."},{"key":"93379_CR19","doi-asserted-by":"publisher","unstructured":"J L, X Q, X Z, et al. Prognostic implications of systemic immune-inflammation index in myocardial infarction patients with and without diabetes: insights from the NOAFCAMI-SH registry. Cardiovasc. Diabetol. ;23(1). (2024). https:\/\/doi.org\/10.1186\/s12933-024-02129-x","DOI":"10.1186\/s12933-024-02129-x"},{"issue":"11","key":"93379_CR20","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/cvr\/cvae142","volume":"120","author":"TTJ Kufazvinei","year":"2024","unstructured":"Kufazvinei, T. T. J., Chai, J., Boden, K. A., Channon, K. M. & Choudhury, R. P. Emerging opportunities to target inflammation: myocardial infarction and type 2 diabetes. Cardiovasc. Res. 120 (11), 1241\u20131252. https:\/\/doi.org\/10.1093\/cvr\/cvae142 (2024).","journal-title":"Cardiovasc. Res."},{"issue":"20","key":"93379_CR21","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","volume":"138","author":"K Thygesen","year":"2018","unstructured":"Thygesen, K. et al. Fourth universal definition of myocardial infarction (2018). Circulation 138 (20), e618\u2013e651. https:\/\/doi.org\/10.1161\/CIR.0000000000000617 (2018).","journal-title":"Circulation"},{"issue":"19","key":"93379_CR22","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker, L. A. et al. New Creatinine- and Cystatin C-Based equations to estimate GFR without race. N Engl. J. Med. 385 (19), 1737\u20131749. https:\/\/doi.org\/10.1056\/NEJMoa2102953 (2021).","journal-title":"N Engl. J. Med."},{"issue":"5S","key":"93379_CR23","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2022.06.008","volume":"102","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group","year":"2022","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 102 (5S), S1\u2013S127. https:\/\/doi.org\/10.1016\/j.kint.2022.06.008 (2022).","journal-title":"Kidney Int."},{"issue":"25","key":"93379_CR24","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","volume":"377","author":"H Thiele","year":"2017","unstructured":"Thiele, H. et al. PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl. J. Med. 377 (25), 2419\u20132432. https:\/\/doi.org\/10.1056\/NEJMoa1710261 (2017).","journal-title":"N Engl. J. Med."},{"issue":"3","key":"93379_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41569-020-00457-5","volume":"18","author":"P Gaba","year":"2021","unstructured":"Gaba, P., Gersh, B. J., Ali, Z. A., Moses, J. W. & Stone, G. W. Complete versus incomplete coronary revascularization: definitions, assessment and outcomes. Nat. Rev. Cardiol. 18 (3), 155\u2013168. https:\/\/doi.org\/10.1038\/s41569-020-00457-5 (2021).","journal-title":"Nat. Rev. Cardiol."},{"issue":"13","key":"93379_CR26","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jama.2023.17002","volume":"330","author":"Writing Group for the CKD Prognosis Consortium","year":"2023","unstructured":"Writing Group for the CKD Prognosis Consortium et al. Estimated glomerular filtration rate, albuminuria, and adverse outcomes: an Individual-Participant data Meta-Analysis. JAMA 330 (13), 1266\u20131277. https:\/\/doi.org\/10.1001\/jama.2023.17002 (2023).","journal-title":"JAMA"},{"issue":"13","key":"93379_CR27","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1056\/NEJMoa041365","volume":"351","author":"NS Anavekar","year":"2004","unstructured":"Anavekar, N. S. et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl. J. Med. 351 (13), 1285\u20131295. https:\/\/doi.org\/10.1056\/NEJMoa041365 (2004).","journal-title":"N Engl. J. Med."},{"key":"93379_CR28","doi-asserted-by":"publisher","first-page":"e075062","DOI":"10.1136\/bmj-2023-075062","volume":"381","author":"J Hussain","year":"2023","unstructured":"Hussain, J. et al. Associations between modest reductions in kidney function and adverse outcomes in young adults: retrospective, population based cohort study. BMJ 381, e075062. https:\/\/doi.org\/10.1136\/bmj-2023-075062 (2023).","journal-title":"BMJ"},{"issue":"6","key":"93379_CR29","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nrneph.2017.52","volume":"13","author":"C Zoccali","year":"2017","unstructured":"Zoccali, C. et al. The systemic nature of CKD. Nat. Rev. Nephrol. 13 (6), 344\u2013358. https:\/\/doi.org\/10.1038\/nrneph.2017.52 (2017).","journal-title":"Nat. Rev. Nephrol."},{"issue":"3","key":"93379_CR30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1053\/j.ajkd.2019.02.013","volume":"74","author":"K Izumaru","year":"2019","unstructured":"Izumaru, K. et al. Reduced estimated GFR and cardiac remodeling: A Population-Based autopsy study. Am. J. Kidney Dis. 74 (3), 373\u2013381. https:\/\/doi.org\/10.1053\/j.ajkd.2019.02.013 (2019).","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"93379_CR31","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1161\/HYPERTENSIONAHA.109.142042","volume":"55","author":"SP Levick","year":"2010","unstructured":"Levick, S. P., Murray, D. B., Janicki, J. S. & Brower, G. L. Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive heart. Hypertens. Dallas Tex. 1979. 55 (2), 270\u2013276. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.142042 (2010).","journal-title":"Hypertens. Dallas Tex. 1979"},{"key":"93379_CR32","doi-asserted-by":"publisher","unstructured":"Kalinskaya, A. et al. Circulating cytokines in myocardial infarction are associated with coronary blood flow. Front. Immunol. 13 https:\/\/doi.org\/10.3389\/fimmu.2022.837642 (2022).","DOI":"10.3389\/fimmu.2022.837642"},{"issue":"9","key":"93379_CR33","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/eurheartj\/eht367","volume":"35","author":"S Kaptoge","year":"2014","unstructured":"Kaptoge, S. et al. Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis. Eur. Heart J. 35 (9), 578\u2013589. https:\/\/doi.org\/10.1093\/eurheartj\/eht367 (2014).","journal-title":"Eur. Heart J."},{"issue":"1","key":"93379_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu, S. D. & Frangogiannis, N. G. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ. Res. 119 (1), 91\u2013112. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.303577 (2016).","journal-title":"Circ. Res."},{"issue":"5","key":"93379_CR35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","volume":"11","author":"NG Frangogiannis","year":"2014","unstructured":"Frangogiannis, N. G. The inflammatory response in myocardial injury, repair, and remodelling. Nat. Rev. Cardiol. 11 (5), 255\u2013265. https:\/\/doi.org\/10.1038\/nrcardio.2014.28 (2014).","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"93379_CR36","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12933-022-01583-9","volume":"21","author":"J He","year":"2022","unstructured":"He, J. et al. High neutrophil to lymphocyte ratio with type 2 diabetes mellitus predicts poor prognosis in patients undergoing percutaneous coronary intervention: a large-scale cohort study. Cardiovasc. Diabetol. 21 (1), 156. https:\/\/doi.org\/10.1186\/s12933-022-01583-9 (2022).","journal-title":"Cardiovasc. Diabetol."},{"issue":"3","key":"93379_CR37","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1016\/j.ijcard.2013.04.095","volume":"168","author":"M Suzuki","year":"2013","unstructured":"Suzuki, M. et al. Critical role of systemic inflammation in patients with ST-segment elevation myocardial infarction complicated with renal dysfunction. Int. J. Cardiol. 168 (3), 3062\u20133064. https:\/\/doi.org\/10.1016\/j.ijcard.2013.04.095 (2013).","journal-title":"Int. J. Cardiol."},{"issue":"9","key":"93379_CR38","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1097\/CCM.0b013e31828a67b2","volume":"41","author":"S van Diepen","year":"2013","unstructured":"van Diepen, S. et al. The systemic inflammatory response syndrome in patients with ST-Segment elevation myocardial infarction. Crit. Care Med. 41 (9), 2080\u20132087. https:\/\/doi.org\/10.1097\/CCM.0b013e31828a67b2 (2013).","journal-title":"Crit. Care Med."},{"issue":"11","key":"93379_CR39","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1161\/CIRCULATIONAHA.121.056177","volume":"144","author":"N Mewton","year":"2021","unstructured":"Mewton, N. et al. Effect of Colchicine on myocardial injury in acute myocardial infarction. Circulation 144 (11), 859\u2013869. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.056177 (2021).","journal-title":"Circulation"},{"issue":"8","key":"93379_CR40","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.tcm.2020.10.007","volume":"31","author":"A Aimo","year":"2021","unstructured":"Aimo, A. et al. Colchicine for the treatment of coronary artery disease. Trends Cardiovasc. Med. 31 (8), 497\u2013504. https:\/\/doi.org\/10.1016\/j.tcm.2020.10.007 (2021).","journal-title":"Trends Cardiovasc. Med."},{"issue":"4","key":"93379_CR41","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jacbts.2017.07.001","volume":"2","author":"JA Rymer","year":"2017","unstructured":"Rymer, J. A. & Newby, L. K. Failure to launch: targeting inflammation in acute coronary syndromes. JACC Basic. Transl Sci. 2 (4), 484\u2013497. https:\/\/doi.org\/10.1016\/j.jacbts.2017.07.001 (2017).","journal-title":"JACC Basic. Transl Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93379-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93379-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93379-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T12:07:13Z","timestamp":1743682033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93379-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["93379"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-93379-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"5 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The CSPR trial was conducted in accordance with the Declaration of Helsinki and was approved by all institutional ethics and review committees.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}],"article-number":"11075"}}